ID
MACK

Integral Derivatives’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Integral Derivatives’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,390
Closed -$77K – 751
2016
Q4 		$77K Buy
+2,390
New +$77K ﹤0.01% 245